BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1167323)

  • 1. Effect of hydrocortisone on in vitro cellular immunity to viruses in man.
    Thong YH; Hensen SA; Vincent MM; Rola-Pleszcynski M; Walser JB; Bellanti JA
    Clin Immunol Immunopathol; 1975 Jan; 3(3):363-8. PubMed ID: 1167323
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired cellular immunity to rubella virus in congenital rubella.
    Fuccillo DA; Steele RW; Hensen SA; Vincent MM; Hardy JB; Bellanti JA
    Infect Immun; 1974 Jan; 9(1):81-4. PubMed ID: 4808855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired in vitro cell-mediated immunity to rubella virus during pregnancy.
    Thong YH; Steele RW; Vincent MM; Hensen SA; Bellanti JA
    N Engl J Med; 1973 Sep; 289(12):604-6. PubMed ID: 4269242
    [No Abstract]   [Full Text] [Related]  

  • 4. A 51 Cr microassay technique for cell-mediated immunity to viruses.
    Steele RW; Hensen SA; Vincent MM; Fuccillo DA; Bellanti JA
    J Immunol; 1973 Jun; 110(6):1502-10. PubMed ID: 4712922
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine.
    Steele RW; Hensen SA; Vincent MM; Fuccillo DA; Bellanti JA
    J Infect Dis; 1974 Nov; 130(5):449-53. PubMed ID: 4472899
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of rubella antibody by hemagglutination inhibition. I. Variables affecting rubella hemagglutination.
    Liebhaber H
    J Immunol; 1970 Apr; 104(4):818-25. PubMed ID: 5462589
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between rubella hemagglutination inhibition antibody (HIA) and rubella induced in vitro lymphocyte tritiated thymidine incorporation.
    Smith KA; Chess L; Mardiney MR
    Cell Immunol; 1973 Aug; 8(2):321-7. PubMed ID: 4725863
    [No Abstract]   [Full Text] [Related]  

  • 8. Persistent rubella virus infection in hamster lung cells.
    Downie JC; Oxford JS
    J Gen Virol; 1969 Jul; 5(1):11-7. PubMed ID: 4309921
    [No Abstract]   [Full Text] [Related]  

  • 9. Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays.
    Rosenberg EB; McCoy JL; Green SS; Donnelly FC; Siwarski DF; Levine PH; Herberman RB
    J Natl Cancer Inst; 1974 Feb; 52(2):345-52. PubMed ID: 4131425
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effects of bilirubin on cellular immune responses in man.
    Rola-Plezczynski M; Hensen SA; Vincent MM; Bellanti JA
    J Pediatr; 1975 May; 86(5):690-6. PubMed ID: 124327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of immune lymphocytes to detect expression of herpetic genome.
    Sprecher-Goldberger S; Thiry L; Vandenbussche P
    Nature; 1974 Aug; 250(5468):678-9. PubMed ID: 4369425
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity.
    Rola-Pleszczynski M; Hurtado RC; Woody JN; Sell KW; Vincent MM; Hensen SA; Bellanti JA
    J Immunol; 1975 Jul; 115(1):239-42. PubMed ID: 50349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte-mediated cytotoxicity to viruses in patients with multiple sclerosis: presence of a blocking factor.
    Rola-Pleszczynski M; Abernathy M; Vincent MM; Hensen SA; Bellanti JA
    Clin Immunol Immunopathol; 1976 Mar; 5(2):165-72. PubMed ID: 1084246
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxic activity of lymphocytes. 3. Standardization of measurement of cell-mediated lysis.
    Lucas ZJ; Walker SM
    J Immunol; 1974 Jul; 113(1):209-24. PubMed ID: 4598888
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.
    Vesikari T; Kanra GY; Buimovici-Klein E; Cooper LZ
    Clin Exp Immunol; 1975 Jan; 19(1):33-43. PubMed ID: 1081925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agents.
    Foley GE; Lazarus H
    Biochem Pharmacol; 1967 Apr; 16(4):659-74. PubMed ID: 4226738
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell-mediated lympholysis after sensitization in unidirectional mixed lymphocyte culture in man.
    Bonnard GD; Lemos L; Chappuis M
    Scand J Immunol; 1974; 3(1):97-106. PubMed ID: 4275198
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon production in lymphocyte cultures after rubella infection in humans.
    Buimovici-Klein E; Weiss KE; Cooper LZ
    J Infect Dis; 1977 Mar; 135(3):380-5. PubMed ID: 850076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of circulating and secretory antibody and cell-mediated immunity following immunization.
    Waldman RH; Ganguly R
    Dev Biol Stand; 1975; 28():273-84. PubMed ID: 1126572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymohocyte-mediated cytotoxicity against influenza virus-infected cells: an in vitro method.
    Greenberg SB; Criswell BS; Couch RB
    J Immunol; 1975 Aug; 115(2):601-3. PubMed ID: 1151068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.